Skip to main content
. Author manuscript; available in PMC: 2012 Dec 6.
Published in final edited form as: Curr Biol. 2011 Nov 23;21(23):1979–1987. doi: 10.1016/j.cub.2011.11.002

Figure 6.

Figure 6

Role of WNK1 in the production of PI4P by expressed PI4KIIIα. (A) Chromatogram showing PI4K activity in membranes prepared from HeLa cells transfected with vector or cDNA for PI4KIIIα. Std: PI4P standard. (B) Chromatogram showing PI4P production by membrane-associated recombinant PI4KIIIα from cells that were co-transfected with control oligonucleotide or WNK1 siRNA. Relative knockdown of WNK1 is shown in the Western blot. (C) Mean ± SEM of PI4P production from 5 separate experiments, each with triplicate samples, as shown in panel B. *, p < 0.01 control versus knockdown. (D) Abundance of PI4KIIIα in the post-nuclear supernatant (PNS), cytosol, and membrane fractions from control and WNK1 siRNA-transfected HeLa cells. A western blot at bottom shows relative WNK1 knockdown. (E) Mean ± SEM (5 separate experiments) of PI4KIIIα abundance in the post-nuclear supernatant (PNS), cytosol, and membrane fraction in control (blue) and WNK1 knockdown cell (red), shown relative to the control. *, p < 0.05 between indicated. (F) Whole-cell TRPC6 currents stimulated by WNK11–491 in cells co-transfected with control oligonucleotide or siRNA for human PI4KIIIα, with either empty vector or plasmid that encodes rat PI4KIIIα. (G) Peak WNK1-induced inward current density from panel F. *, p < 0.01 between indicated.

HHS Vulnerability Disclosure